Former NHS CIO Will Smart Joins Alcidion

Alcidion LtdA former national chief information officer for health and social care in England, Will Smart will join the Alcidion Group board in a global role from October. He will provide strategic insight as the company continues to support healthcare organisations in different parts of the world digitise frontline services.

During an extensive career in digital health, Smart has advised senior government ministers, has played leading roles in initiatives including the Global Digital Exemplar programme and has helped to drive technology adoption from within the health technology industry.

Commenting on his new role with Alcidion, Will Smart said: "Alcidion continues to win really interesting projects, as healthcare systems work to advance digitisation. The company deserves mindshare from healthcare CIOs for its very impressive modern, interoperable, standards-based EPR platform, and for technologies now needed to address key issues such as how patients flow across systems. I look forward to sharing ideas and working closely with the Alcidion team, who have proven themselves to be thoughtful and committed in delivering the best possible products and outcomes for customers."

Smart is a former global director of external relations for Dedalus Group. He has also held executive roles at several NHS trusts during his career, including group chief information officer for the Royal Free London NHS Foundation Trust.

He will remain in post as digital non-executive director for Great Western Hospitals NHS Foundation Trust, from where he serves as a member of the Acute Hospitals Alliance EPR Joint Committee, which is responsible for overseeing the delivery of a shared EPR across three NHS trusts.

Smart remains a director of CareTech Partners Limited, which provides digital advisory and consultancy support. He is also a member of Health and Social Care Council at techUK, a trade association which represents and champions companies in the UK technology sector.

Kate Quirke, CEO for Alcidion, said: "Will's extensive experience in digitising frontline services will help to inform our strategic direction as we continue to serve more and more healthcare providers throughout the world, with genuine solutions to meet their needs. We look forward to inspiring and open discussions that will help to further enhance our effectiveness in this mission."

About Alcidion

Alcidion Group Limited (Alcidion) has a simple purpose, that is, to transform healthcare with proactive, smart, intuitive technology solutions that improve the efficiency and quality of patient care in healthcare organisations, worldwide.

Alcidion offers a complementary set of software products and technical services that create a unique offering in the global healthcare market. Based on the flagship product, Miya Precision, the solutions aggregate meaningful information to centralised dashboards, support interoperability, facilitate communication and task management in clinical and operational settings and deliver Clinical Decision Support at the point of care; all in support of Alcidion’s mission to improve patient outcomes.

Since listing on the ASX in 2011, Alcidion has acquired multiple healthcare IT companies and expanded its foothold in the UK, Australia, and New Zealand to now service over 400 hospitals and 87 healthcare organisations, with further geographical expansion planned.

With over 20 years of healthcare experience, Alcidion brings together the very best in technology and market knowledge to deliver solutions that make healthcare better for everyone.

Most Popular Now

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...

New AI Tool Makes Medical Imaging Proces…

When doctors analyze a medical scan of an organ or area in the body, each part of the image has to be assigned an anatomical label. If the brain is...